J. C. Soria, E. Smit, D. Khayat, B. Besse, X. Yang, C. P. Hsu, D. Reese, J. Wiezorek and F. Blackhall, “Phase 1b Study of Dulanermin (Recombinant Human Apo2L/ TRAIL) in Combination with Paclitaxel, Carboplatin, and Bevacizumab in Patients with Advanced Non-Squamous Non-Small-Cell Lung Cancer,” Journal of Clinical Oncology, Vol. 28, No. 9, 2010, pp. 1527-1533. http://dx.doi.org/10.1200/JCO.2009.25.4847

has been cited by the following article:

• TITLE: Development of Small Molecules Activating TRAIL Apoptosis Pathway for Cancer Therapies

  AUTHORS: Anita C. Bellail, Chunhai Hao

  KEYWORDS: Apoptosis Pathway; Apoptosis Pathway

  JOURNAL NAME: Open Journal of Apoptosis, Vol.2 No.4, October 31, 2013

  ABSTRACT: Development of Small Molecules Activating TRAIL Apoptosis Pathway for Cancer Therapies